文献速递其他结缔组织病

抗磷脂抗体女性妊娠成功率及对肝素/阿司匹林反应随GAPSS评分不同而异

Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score.
PubMed 文献 · Semin Arthritis Rheum · 2020-01-28

结果显示总体活产率70.5%,31%患者至少发生一次妊娠病态;高危组全部发生妊娠病态且活产率显著低于其他组,中危组妊娠病态率显著高于低危组。结论提示GAPSS可能有助于识别对标准治疗反应更可能好的患者。

要点

  • GAPSS低危(<6)患者标准治疗后妊娠病态率15.3%,中危43.9%,差异显著。
  • 高危(≥12)组全部发生妊娠病态,活产率仅40.7%,显著低于其他组。
  • 总体活产率70.5%,但31%患者仍发生妊娠病态,提示标准治疗不足。

核心结论

  • GAPSS评分可能有助于识别对标准治疗(低剂量阿司匹林和/或低分子肝素)反应可能性更高的aPL阳性妊娠女性。

主要发现

  • 总体活产率为70.5%(248/352次妊娠),45例(31%)患者至少发生一次妊娠病态。
  • 高危组全部患者发生妊娠病态,中危组妊娠病态率43.9%(29例)显著高于低危组15.3%(11例),p<0.001。
  • 高危组活产率40.7%(11次)显著低于中危组62.1%(100次)和低危组82.5%(137次),p<0.05;中危组活产率也显著低于低危组,p<0.001。

关键数值与推荐

  • GAPSS分组阈值:低危<6,中危6-11,高危≥12。
  • 妊娠病态定义为早期或晚期妊娠病态。
  • 标准治疗指低剂量阿司匹林和低分子肝素。

临床怎么用

  • 对aPL阳性妊娠女性可计算GAPSS评分以分层风险,低危者标准治疗反应较好,中高危者需更密切监测或考虑强化治疗。

局限性

  • 高危组样本量仅5例,结果解释需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The current treatment to prevent pregnancy morbidity (PM) associated with antiphospholipid antibodies (aPL) is based on the use of low dose aspirin and low molecular weight heparin (henceforth defined as standard of care (SoC) treatment). Despite the SoC, up to 30% of women with aPL continue to have pregnancy complications. The global antiphospholipid syndrome (APS) score (GAPSS) is a tool to quantify the risk for the aPL-related clinical manifestations. In this study, we investigated the individual clinical response to SoC in women with aPL after stratifying them according to their GAPSS. METHODS: One-hundred-fourty-three women (352 pregnancies) with aPL ever pregnant treated with SoC therapy were included. The patients GAPSS was then grouped according to the patients' GAPSS into low risk (< 6), medium risk (6-11), and high risk (≥12). RESULTS: The live birth rate was 70.5% (248 out of the 352 pregnancies), 45 patients (31%) experienced at least one event of PM, defined as early or late. Patients were stratified according to GAPSS values, in order to identify a low risk group (GAPSS <6, n = 72), a medium risk group (GAPSS 6-11, n = 66) and a high risk group (GAPSS ≥12, n = 5). When considering patients who ever experienced any PM while treated with SoC, all patients in the high risk group experienced PM, while patients in the medium group had a significant higher rate of PM when compared to the low risk group [29 (43.9%) patients V.s. 11 (15.3%), respectively; p < 0.001]. When analysing the number of pregnancies in the three groups, patients in the high risk group had significantly lower live birth rates, when compared to the other groups [11 (40.7%) live births vs. 100 (62.1%) and 137 (82.5%), respectively; p < 0.05]. Furthermore, patients with medium risk group also had significantly lower live birth rates, when compared to the lower risk group (p < 0.001). CONCLUSIONS: GAPSS might be a valuable tool for to identify patients with a higher likelihood of response to SoC.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Radin M, Cecchi I, Schreiber K, et al. Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score. Semin Arthritis Rheum. 2020. PMID: 32089355. doi:10.1016/j.semarthrit.2020.01.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。